Global Hypertrophic And Keloid Scar Treatment Market Size 2024, Forecast To 2033
6 Mar, 2024
The hypertrophic and keloid scar treatment market has experienced rapid growth in recent years, rising from $6.91 billion in 2023 to $7.67 billion in 2024, with a compound annual growth rate (CAGR) of 11.0%. This growth can be attributed to the increased incidence of hypertrophic and keloid scars, advancements in scar assessment, widespread adoption of topical treatments, surgical and invasive procedures, and patient demand for scar improvement. Looking forward, the market is expected to continue its strong growth trajectory, reaching $11.14 billion by 2028, with a CAGR of 9.8%. Growth drivers in the forecast period include emerging minimally invasive interventions, advancements in scar revision techniques, growing interest in combination therapies, increasing awareness and early intervention, and global aesthetic trends. Major trends include emerging injectable therapies, combination therapies for synergistic effects, patient-centric approaches, scar assessment technologies, and telemedicine for follow-up and consultations.
Global Hypertrophic And Keloid Scar Treatment Market Key Driver
The hypertrophic and keloid scar treatment market is anticipated to witness significant growth propelled by the increasing number of road accidents and burn cases. Road accidents, involving at least one vehicle and individuals, necessitate attention and effective treatment measures. Hypertrophic and keloid scar treatments aim to reduce scar height and tightness, particularly for individuals injured in road accidents. Data from the National Highway Traffic Safety Administration in August 2022 indicates a concerning rise in motor vehicle traffic accident fatalities, with approximately 9,560 fatalities reported in the first three months of 2022, marking a nearly 7% increase compared to the same period in 2021. Moreover, the mortality rate surged from 1.25 fatalities per 100 million vehicle miles in the first quarter of 2021 to 1.27 fatalities per 100 million vehicle miles in the first quarter of 2022. This surge in road accidents and burn cases underscores the demand for hypertrophic and keloid scar treatments, reflecting market size projections for 2023, 2024, and 2028.
Get A Free Sample Of The Global Hypertrophic And Keloid Scar Treatment Market ReportGlobal Hypertrophic And Keloid Scar Treatment Market Segments
The hypertrophic and keloid scar treatment market covered in this report is segmented –
1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments
2) By Products: Topical Products, Laser Products, Injectables, Other Products
3) By Scar: Hypertrophic Scars, Keloid Scars
4) By End-Use: Hospitals, Clinics, Other End-Users
By Geography:The regions covered in the hypertrophic and keloid scar treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the hypertrophic and keloid scar treatment market in 2023. Asia-pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Hypertrophic And Keloid Scar Treatment Industry Players
Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Mylan N.V., Stratpharma AG, Revitol Corporation Inc., Quantum Health, Scarfade, Biodermis, Renovo Group plc, Mederma, Silagen
Get The Full Global Hypertrophic And Keloid Scar Treatment Market Report
Hypertrophic And Keloid Scar Treatment Market Overview
Hypertrophic and keloid scar treatment refers to the treatment of scars that do not grow beyond the boundaries of the original wound and spread to the surrounding skin. The hypertrophic scars are contained within the area of injury, while keloids spread outside the boundaries of the initial damage and do not regress.
Hypertrophic And Keloid Scar Treatment Global Market Report 2023 provides data on the global hypertrophic and keloid scar treatment market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The hypertrophic and keloid scar treatment market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.